Cargando…

PB2185: EFFECT OF NEW OR WORSENING ANEMIA ON CLINICAL OUTCOMES IN PATIENTS WITH MYELOFIBROSIS (MF) TREATED WITH RUXOLITINIB (RUX): A POST HOC ANALYSIS OF THE COMFORT-I AND -II TRIALS

Detalles Bibliográficos
Autores principales: Al-Ali, Haifa Kathrin, Mesa, Ruben, Hamer-Maansson, J.E., Braunstein, Evan, Harrison, Claire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429189/
http://dx.doi.org/10.1097/01.HS9.0000975492.85817.f0
_version_ 1785090648524718080
author Al-Ali, Haifa Kathrin
Mesa, Ruben
Hamer-Maansson, J.E.
Braunstein, Evan
Harrison, Claire
author_facet Al-Ali, Haifa Kathrin
Mesa, Ruben
Hamer-Maansson, J.E.
Braunstein, Evan
Harrison, Claire
author_sort Al-Ali, Haifa Kathrin
collection PubMed
description
format Online
Article
Text
id pubmed-10429189
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104291892023-08-17 PB2185: EFFECT OF NEW OR WORSENING ANEMIA ON CLINICAL OUTCOMES IN PATIENTS WITH MYELOFIBROSIS (MF) TREATED WITH RUXOLITINIB (RUX): A POST HOC ANALYSIS OF THE COMFORT-I AND -II TRIALS Al-Ali, Haifa Kathrin Mesa, Ruben Hamer-Maansson, J.E. Braunstein, Evan Harrison, Claire Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429189/ http://dx.doi.org/10.1097/01.HS9.0000975492.85817.f0 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Al-Ali, Haifa Kathrin
Mesa, Ruben
Hamer-Maansson, J.E.
Braunstein, Evan
Harrison, Claire
PB2185: EFFECT OF NEW OR WORSENING ANEMIA ON CLINICAL OUTCOMES IN PATIENTS WITH MYELOFIBROSIS (MF) TREATED WITH RUXOLITINIB (RUX): A POST HOC ANALYSIS OF THE COMFORT-I AND -II TRIALS
title PB2185: EFFECT OF NEW OR WORSENING ANEMIA ON CLINICAL OUTCOMES IN PATIENTS WITH MYELOFIBROSIS (MF) TREATED WITH RUXOLITINIB (RUX): A POST HOC ANALYSIS OF THE COMFORT-I AND -II TRIALS
title_full PB2185: EFFECT OF NEW OR WORSENING ANEMIA ON CLINICAL OUTCOMES IN PATIENTS WITH MYELOFIBROSIS (MF) TREATED WITH RUXOLITINIB (RUX): A POST HOC ANALYSIS OF THE COMFORT-I AND -II TRIALS
title_fullStr PB2185: EFFECT OF NEW OR WORSENING ANEMIA ON CLINICAL OUTCOMES IN PATIENTS WITH MYELOFIBROSIS (MF) TREATED WITH RUXOLITINIB (RUX): A POST HOC ANALYSIS OF THE COMFORT-I AND -II TRIALS
title_full_unstemmed PB2185: EFFECT OF NEW OR WORSENING ANEMIA ON CLINICAL OUTCOMES IN PATIENTS WITH MYELOFIBROSIS (MF) TREATED WITH RUXOLITINIB (RUX): A POST HOC ANALYSIS OF THE COMFORT-I AND -II TRIALS
title_short PB2185: EFFECT OF NEW OR WORSENING ANEMIA ON CLINICAL OUTCOMES IN PATIENTS WITH MYELOFIBROSIS (MF) TREATED WITH RUXOLITINIB (RUX): A POST HOC ANALYSIS OF THE COMFORT-I AND -II TRIALS
title_sort pb2185: effect of new or worsening anemia on clinical outcomes in patients with myelofibrosis (mf) treated with ruxolitinib (rux): a post hoc analysis of the comfort-i and -ii trials
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429189/
http://dx.doi.org/10.1097/01.HS9.0000975492.85817.f0
work_keys_str_mv AT alalihaifakathrin pb2185effectofneworworseninganemiaonclinicaloutcomesinpatientswithmyelofibrosismftreatedwithruxolitinibruxaposthocanalysisofthecomfortiandiitrials
AT mesaruben pb2185effectofneworworseninganemiaonclinicaloutcomesinpatientswithmyelofibrosismftreatedwithruxolitinibruxaposthocanalysisofthecomfortiandiitrials
AT hamermaanssonje pb2185effectofneworworseninganemiaonclinicaloutcomesinpatientswithmyelofibrosismftreatedwithruxolitinibruxaposthocanalysisofthecomfortiandiitrials
AT braunsteinevan pb2185effectofneworworseninganemiaonclinicaloutcomesinpatientswithmyelofibrosismftreatedwithruxolitinibruxaposthocanalysisofthecomfortiandiitrials
AT harrisonclaire pb2185effectofneworworseninganemiaonclinicaloutcomesinpatientswithmyelofibrosismftreatedwithruxolitinibruxaposthocanalysisofthecomfortiandiitrials